Dectova is an antiviral medicine used to treat complicated and potentially life-threatening influenza (flu) caused by either the influenza A or B virus in adults and children from 6 months of age. Complicated influenza is a severe flu infection that requires hospitalisation of the patient. The medicine is used when the virus is resistant to other flu treatments or when other antiviral treatments, including inhaled zanamivir are not suitable for the patient. Dectova contains the active substance zanamivir.
Therapeutic Indication
### Therapeutic indication Dectova is indicated for the treatment of complicated and potentially life-threatening influenza A or B virus infection in adult and paediatric patients (aged ?6 months) when: - The patient’s influenza virus is known or suspected to be resistant to anti-influenza medicinal products other than zanamivir, and/or - Other anti-viral medicinal products for treatment of influenza, including inhaled zanamivir, are not suitable for the individual patient. Dectova should be used in accordance with official guidance.
Therapeutic Area (MeSH)
ATC Code
J05AH01
ATC Item
zanamivir
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Dectova
Medicine Name
Dectova
Aliases
N/ANo risk management plan link.
